Loading organizations...
§ Venture Capital · Cincinnati, OH, USA
A biopharmaceutical company that acquires compounds and develops therapies for cardiometabolic, renal, gastrointestinal, and obesity.
CinRx Pharma has raised $83.0M across 2 funding rounds.
Key people at CinRx Pharma.
CinRx Pharma has raised $83.0M in total across 2 funding rounds.
CinRx Pharma is a Cincinnati, Ohio-based biopharmaceutical company that utilizes a hub-and-spoke business model to license or acquire promising medical compounds and build specialized portfolio companies around them. The platform advances these early-stage therapies through rigorous clinical development and regulatory approval processes, focusing primarily on cardiometabolic, renal, gastrointestinal, and obesity treatments. The organization has raised a total of $176 million in capital, which includes a $73 million financing round secured in May 2024 with backing from lead investor Medpace Investors LLC. CinRx currently manages a diverse portfolio of seven distinct drug development companies, including active subsidiaries such as CinDome and CinSano. Its previous portfolio company, CinCor, successfully completed an initial public offering in 2022 before being acquired by AstraZeneca for $1.8 billion the following year. CinRx Pharma was founded in 2015 by Jon Isaacsohn.
Key people at CinRx Pharma.
CinRx Pharma has raised $83.0M across 2 funding rounds. Most recently, it raised $73.0M Other Equity in May 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 30, 2024 | $73M Venture Round | — | — | Announced |
| Nov 28, 2017 | $10M Series B | — | — | Announced |
CinRx Pharma has raised $83.0M in total across 2 funding rounds.
